FTRE Earnings — Fortrea Holdings Inc. Common Stock Post-ER Performance | BigEarnings
FTRE — Fortrea Holdings Inc. Common Stock
XNAS · Healthcare · Biotechnology
Price$15.39
Market Cap$1.5B
P/E—
52W Range$3.97 – $18.67
Next Earnings2026-08-05
About Fortrea Holdings Inc. Common Stock
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
